News of the WeekSTEM CELLS

CIRM Awards Seek to Move Cell Therapies to the Clinic

See allHide authors and affiliations

Science  06 Nov 2009:
Vol. 326, Issue 5954, pp. 780-781
DOI: 10.1126/science.326_780a

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Five years after it launched, the California Institute for Regenerative Medicine (CIRM) last week awarded its first disease-oriented grants—$230 million to 14 teams—intended to speed stem cell therapies to patients. In seeming contrast to its original mission, only about one-third of the 4-year grants involve research using embryonic stem (ES) cells. The state created CIRM largely to fund ES cell research, which was lagging because of Bush-era restrictions on the controversial technology.